Literature DB >> 1713669

PMN-elastase in comparison with CRP, antiproteases, and LDH as indicators of necrosis in human acute pancreatitis.

W Uhl1, M Büchler, P Malfertheiner, M Martini, H G Beger.   

Abstract

We analyzed the role of polymorphonuclear granulocytes (PMN)-elastase in predicting the prognosis of patients with acute pancreatitis in comparison with C-reactive protein (CRP), lactate dehydrogenase (LDH), and the two antiproteases alpha 1-antitrypsin (alpha 1-AT) and alpha 2-macroglobulin (alpha 2-M). Fifty-two patients with acute pancreatitis were subdivided according to morphological criteria into 29 patients with edematous pancreatitis and 23 patients with necrotizing pancreatitis. Within 5 days after the onset of acute pancreatitis, the accuracy rates for detecting necrotizing pancreatitis were 86%, 84%, 82%, 72%, and 69%, using cutoff levels of 120 mg/L for CRP, 120 micrograms/L for PMN-elastase, 270 U/L for LDH, 1.5 g/L for alpha 2-M, and 3.5 g/L for alpha 1-AT, respectively. The median peak value of PMN-elastase was reached on day 1 of acute pancreatitis in contrast to the median peak of CRP, which was at its highest between days 3 and 4. PMN-elastase represents a reliable indicator, comparable with CRP, for the staging of acute pancreatitis. The advantage of PMN-elastase over CRP appears to be its earlier increase and the greater dynamism of its serum course. Finally, the results suggest that CT scanning for the evaluation of the extent of intra- and extrapancreatic necrosis could be restricted to those patients with increased values of PMN-elastase and CRP.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1713669     DOI: 10.1097/00006676-199105000-00001

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  33 in total

Review 1.  The role of infection in acute pancreatitis.

Authors:  S W Schmid; W Uhl; H Friess; P Malfertheiner; M W Büchler
Journal:  Gut       Date:  1999-08       Impact factor: 23.059

2.  Admission hematocrit: a simple, useful and early predictor of severe pancreatitis.

Authors:  S Ian Gan; Joseph Romagnuolo
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

Review 3.  Acute pancreatitis at the beginning of the 21st century: the state of the art.

Authors:  Alfredo F Tonsi; Matilde Bacchion; Stefano Crippa; Giuseppe Malleo; Claudio Bassi
Journal:  World J Gastroenterol       Date:  2009-06-28       Impact factor: 5.742

Review 4.  Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference.

Authors:  C Dervenis; C D Johnson; C Bassi; E Bradley; C W Imrie; M J McMahon; I Modlin
Journal:  Int J Pancreatol       Date:  1999-06

5.  Trypsinogen activation peptides (TAP) concentrations in the peritoneal fluid of patients with acute pancreatitis and their relation to the presence of histologically confirmed pancreatic necrosis.

Authors:  D I Heath; C Wilson; A M Gudgeon; A Jehanli; A Shenkin; C W Imrie
Journal:  Gut       Date:  1994-09       Impact factor: 23.059

Review 6.  Severe acute pancreatitis: Clinical course and management.

Authors:  Hans G Beger; Bettina M Rau
Journal:  World J Gastroenterol       Date:  2007-10-14       Impact factor: 5.742

Review 7.  Severe acute pancreatitis: pathogenetic aspects and prognostic factors.

Authors:  Ibrahim-A Al Mofleh
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

8.  Is obesity a significant prognostic factor in acute pancreatitis?

Authors:  C J Tsai
Journal:  Dig Dis Sci       Date:  1998-10       Impact factor: 3.199

9.  Serum profiles of C-reactive protein, interleukin-8, and tumor necrosis factor-alpha in patients with acute pancreatitis.

Authors:  Michael K Digalakis; Iraklis E Katsoulis; Kalliopi Biliri; Katina Themeli-Digalaki
Journal:  HPB Surg       Date:  2010-01-14

Review 10.  Acute biliary pancreatitis: diagnosis and treatment.

Authors:  Zakaria M Hazem
Journal:  Saudi J Gastroenterol       Date:  2009 Jul-Sep       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.